Private Eye

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Directors buying at Covalon Technologies (V:COV)

Updated Friday Jun 02, 2017 03:15 AM EDT

Abe Schwartz, a Director and 10% Holder, acquired 114,796 Common Shares on a direct ownership basis at a price of $1.960 through a prospectus or prospectus exempt offering on June 1st, 2017. The insider also acquired 114,796 Warrants with at an exercise price of $2.300 for 3 years. This represents a $225,000 investment into the company's shares and an account share holdings change of 1.4%.

On the same terms, Murray Miller, a Director, acquired 76,531 Common Shares and 76,531 Warrants. This represents a $150,001 investment into the company's shares and an account share holdings change of 15.8%.

Covalon Technologies is in the Advanced Medical Equipment & Technology Sub Industry Group under the Healthcare Sector.

Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products that manage patient outcomes and save lives in the areas of wound care, infection management and surgical procedures. The Company offers platform technologies: Collagen matrix; Antimicrobial silicone adhesive and Medical coating technology. The collagen matrix platform is used to manufacture products that treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns. The antimicrobial silicone adhesive platform is the basis for a range of pre-surgical, post surgical and vascular access products that are designed to kill any bacteria or yeast that comes into contact with the antimicrobial silicone. The coating technology is a grafting from process, which utilizes photo-polymerization to create active grafting sites.

INK Edge Outlook

CONDITIONS:
Latest
6 months ago
1 year ago
Overall
N/A
N/A
Mixed
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.
Two-week free trial for first time users.
Go to Covalon Technologies Ltd. (COV)'s company page

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Comment On!

No Comments

Twitter

Search (past week) for $COV.CA

  • No tweets found

Stocktwits

Covalon Technologies Ltd.

  • Symbol not found.